Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Programmed cell death 1 (PD-1) inhibitor-related pneumonitis is a rare but clinically serious and potentially life-threatening adverse event. Little is known about its incidence across different tumor types and treatment regimens.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA Oncol

Title: JAMA oncology

Publisher: American Medical Association (AMA)

ISSN (Electronic): 2374-2445

ISSN (Print): 2374-2437

Publication date (Electronic): Dec 01 2016

Volume: 2

Issue: 12

Affiliations

[1 ] Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.

[2 ] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.

[3 ] Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

Article

Publisher Item ID: 2544610

DOI: 10.1001/jamaoncol.2016.2453

PubMed ID: 27540850

SO-VID: 91e93b97-c09b-4c72-b1c1-dac3408ac54e

History

Data availability:

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

Read this article at

Abstract

Related collections

Road 2 Open Meta

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 304